Related Organization(s)

You just read:

/R E P E A T -- Media Invitation - DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists/

News provided by

Fondation de l'Institut de Cardiologie de Montréal

Jun 08, 2015, 05:00 ET